The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
As a novice, can someone tell me how there are so many trades done beyond the normal closing of the market. I see on this stock that trade were done right up until about 5.30pm.
I have always seen this as a well run company. Some seem to think they have overstretched themselves with acquisitions but, given the experience of the team, I see this as a long term growth story with strong organic growth to come. There are not too many quality AIM companies around. But I suspect this is one of only a few gems. I'm hoping it eventually gets taken over. In the meantime I'm holding and will certainly buy more if it drifts down to below £6 without any significant reason.
Bought a few today in the hope (if not the expectation) that tomorrow's results are better than is being anticipated with a view to a quick disposal in the morning.
Nd
I did what I usually do when uncertain which is nothing.....I am close to break even point and can wait this down spell out....
Proleukin trial update hopefully
So did you decide to buy more or hold off Jatw? You were having a conversation with yourself last time you posted haha. Looking forward to results next week.
The FY trading update indicated a lot to like....the sp responded initially but has since drifted away.
these results might start a change in momentum......especially if The accompanying trading update is positive.
The sp tells a different story though.
Relax, this lot generate as much cash as Boohoo... the share price is easy to manipulate before staturatory results, particularly one where a 9-fold increase in EPS will be announced. (Some providers still quote the reported EPS of 4p, which incorrectly gives a PE/Ratio of 150odd, whereas others such as Hargreaves Lansdowne use the adjusted EPS of 55p for last year, giving a ratio of around 12 times). Adjusted EPS is likely to come in around 65p-70p, meaning the PE ratio is only 10x at the moment, which really is bargain basement for a business still in growth, albeit slightly slower than previously. Historically its traded around the 18x level, which would see a share price of £12.50... so wheres the risk at £6.50? Better to come back and look again in 3 months time after results have been announced, and we get a view on outlook for this FY
I would have thought that most investors take more than a passing interest in whether their stake is increasing or decreasing in value. No?
Not really sure why you're looking or worried about the share price. It shouldn't really be a concern if you've done your research and you know the fundamentals of the company.
Well it certainly has been. I can vouch for that because I bought one tranche at just under a tenner. Ah well, you win some you lose some. Just over a fortnight until results so at least we know that news is imminent haha
it's just finding it's true value, this pos isn't worth £9 a share
Funny thing is, it was 900p in June and now its droped by a third in the space of 3 months based on no news whatsoever.
The share price is dribbling away......
Maybe Mr Chilton can mend it....
share price drops before huge increase in earnings announced... haven't ever seen that before *rolls eyes*. I called it a few months ago- price won't increase until earnings are announced - probably at 7:45am on the 17th Sep lol. DYOR, im in and will topup when I can
Great time to buy at sub 700. Assuming results are in line with the trading update which we have no reason to believe they wont be, the SP will rocket well above 700 once results are announced.
Some substantial late trades last couple of days. Clinigen starting to bubble again. Just need it to come to the boil. Could do with a nice steady run up to results day in 4 weeks time
I would expect the DT Questor column to bring in a decent number of new investors. 700-730 is a good range for them to start in and they should do well if the Iovance story is confirmed.....it was trailed in a clinigen RNS earlier this year.
This company needs to get some positive feedback going.
Some big trades yesterday and a +6% start to the day. Nice
The write up includes the following observation - “ In the next few weeks, Iovance Therapeutics are expected to file in America for approval for a therapy that involved Proleukin to treat melanoma. Analysts at Liberum think that a success here could drive Clinigen’s earnings 50% higher in the medium term”
Positive write up and a buy recommendation in the Business section of today’s Telegraph
one of those no news climbs to circa 900 again, i really want what's owed out of this pos
Gawd bless Clinigen! The only blue in my portfolio of shares today
Septembers Results will indeed be interesting, because unlike many that have been making statements, based on guess work it seems, to be fair CLIN seem to have resisted making much of a statement regarding expectations due to covid scenario, whilst many will simply see pharma and assume the sector as a whole should be doing good because of money poured in for covid related things, CLIN does have a much more broad business model, and with certain patent protections ending and generic versions of to products becoming available, exactly where the results will fall in the good to bad scale is going to make for interesting reading.
Personally, i think they will be ok, perhaps not stella, but certainly better than a number of companies lately.
The stop loss thing is an interesting scenario, I know that when limit sells/stop losses are in place, those shares can't be loaned out for shorting purposes, but i'm not sure if the MMs will know where those limits are placed, that would require the data to be divulged by the brokers, and i'm not sure if that's allowed.
Peel hunt (have to say that carefully) have downgraded to hold with a target of 820.
That would be the same peel hunt that reiterated 1280 only a few weeks ago.
Suspect today’s movement is reaction to other pharma and bios on Aim.
ABCam down 5-7% on its trading update and cautious US trading.
I find Aim stocks often open with a 5% bid offer margin over previous close and then It moves towards one end or the other....today it was down after several days of ups. Nothing to worry about too much.
Even FTSE100 largest stock has been volatile with 2-3% movements and 5% on occasion, so volatility in smaller stocks likely to be higher in the medium term.